Hyun Sik Yoon
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 5
Publications (10 Years): 5
Top Venues
Publications
- Joongwon Choi, Kyung Hwan Kim, Hyung Suk Kim, Hyun Sik Yoon, Jung Hoon Kim, Jin-Wook Kim, Yong Seong Lee, Se Young Choi, In Ho Chang, Young Hwii Ko, Wan Song, Byung Chang Jeong, Jong-Kil NamComparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study. Investigative and clinical urology 65 (3) (2024)
- Joongwon Choi, Kyung Hwan Kim, Hyung Suk Kim, Hyun Sik Yoon, Jung Hoon Kim, Jin-Wook Kim, Yong Seong Lee, Se Young Choi, In Ho Chang, Young Hwii Ko, Wan Song, Byung Chang Jeong, Jong-Kil NamComparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study. Investigative and clinical urology 65 (3) (2024)
- Joongwon Choi, Kyung Hwan Kim, Hyung Suk Kim, Hyun Sik Yoon, Jung Hoon Kim, Jin-Wook Kim, Yong Seong Lee, Se Young Choi, In Ho Chang, Young Hwii Ko, Wan Song, Byung Chang Jeong, Jong-Kil NamComparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study. Investigative and clinical urology 65 (3) (2024)
- Joongwon Choi, Kyung Hwan Kim, Hyung Suk Kim, Hyun Sik Yoon, Jung Hoon Kim, Jin-Wook Kim, Yong Seong Lee, Se Young Choi, In Ho Chang, Young Hwii Ko, Wan Song, Byung Chang Jeong, Jong-Kil NamComparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study. Investigative and clinical urology 65 (3) (2024)